View allAll Photos Tagged Brainstorming

035

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

PATIENT TRIALS WE CAN ACTUALLY LEARN FROM

Hosted by City of Hope

The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health

 

Matt de Silva, Co-Founder, CEO and Director, Notable Labs

Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator

Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

011

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:10 PM

PRECISION MEDICINE: WHERE IT’S WORKING AND WHY

The tools of molecular medicine, today, are homing in on human disease with a precision that could only be imagined a decade ago. New advances in big data, genomic medicine, and supercomputing are paving the way for targeted, personalized treatment. What has been the clinical impact so far—and what can we really expect in the five years to come? A deep dive with three individuals who are putting these tools into practice.

 

Kathy Giusti, Founder, Multiple Myeloma Research Foundation (MMRF); Faculty Co-chair, Kraft Precision Medicine Accelerator, Harvard Business School

Othman Laraki, Co-Founder and CEO, Color

Dr. Vijay Pande, General Partner, Andreessen Horowitz

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

005

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

3:10 PM

THE BORDERLESS WORLD

If we’ve learned anything over past decades as we shape health care policy, it’s that the lines on the global map are thin and permeable, when they exist at all. From the spread of disease and emerging pathogens to the logistics of drug development and medical manufacturing, borders are increasingly irrelevant. We press some globally minded thinkers on how enterprises can manage the challenges of an increasingly connected planet—and better yet, tap the power of a connected world.

 

Joe Almeida, Chairman, President and CEO, Baxter International

George Barrett, Executive Chairman, Cardinal Health

Michael Milken, Chairman, Milken Institute

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

034

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

HEALTH CARE AND THE FOURTH INDUSTRIAL REVOLUTION

Hosted by Herman Miller

The industrial revolutions of yore heralded a transition from hand-powered production methods to machine-driven ones and the advent of mass production. The next industrial revolution is a decidedly digital one—and its implications for health care may be more significant than for any other industry. Far beyond telemedicine, the digital age isn’t just changing how we do medicine, but also how we define it. From the health gig economy to AI-run hospitals to on-demand diagnostics, technology is prompting a never-ending question: Where will this fourth revolution take us next?

 

Hema Budaraju, Product Lead, Health, Facebook

Sally Daub, CEO, Enlitic

Sajid Rahman, CEO, Telenor Health

Dr. Roy Schoenberg, President and CEO, American Well

Owen Tripp, Co-Founder and CEO, Grand Rounds

Moderator: Dr. David B. Agus, University of Southern California

Introduction: Mike O’Toole, Senior Vice President of Sales, Herman Miller

 

Photograph by Stuart Isett/Fortune

007

Monday, September 24, 2018

Fortune Brainstorm Reinvent

Chicago, IL, USA

 

3:15 PM

EMOTION ARTIFICIAL INTELLIGENCE: THE HERE AND NOW

While AI may conjure images of robots and computers, the next frontier actually involves machines that can read your emotions. Research scientist and entrepreneur Rana el Kaliouby’s company Affectiva has collected four billion facial frames from 87 countries — and, in the process, signed up 25% of the world’s biggest companies as users. She’ll share the potential of emotion AI, from market research to talent acquisition and reskilling.

 

Dr. Rana el Kaliouby, Co-founder and CEO, Affectiva

 

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

012

Monday, July 16th, 2018

Fortune Brainstorm Tech

 

4:10 PM

GOOGLE’S GURU OF DESIGN

Mobile, aural, personal—we interact with today’s technology in radically different ways than before. Hear how a top Google design guru is harnessing her employer’s computing muscle for surprisingly human experiences.

Speaker: Ivy Ross, Vice President, Design for Hardware, Google

Interviewer: Brian O’Keefe, Deputy Editor, Fortune

 

Photograph by Michael Faas/Fortune

025

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

10:45 AM

CLIMBING OUT OF LAST PLACE: WEST VIRGINIA AND WELL-BEING

West Virginia consistently ranks last out of the 50 U.S. states when it comes to well-being—with the state levels of obesity, poverty, unemployment, and opioid abuse at or near the worst in the nation. But a surprising ray of hope is on the horizon—a new clinical program designed to help the Mountain State address these issues in a radical way. We offer an early look.

 

Dr. E. Gordon Gee, President, West Virginia University

Dr. Clay Marsh, Vice President and Executive Dean for Health Sciences, West Virginia University

Dr. Ali Rezai, Executive Chair, Vice President and Associate Dean, WVU Rockefeller Neuroscience Institute

 

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

093909

Mina Velando

 

brainstormer:

becoming fortunate

downtown

theater

  

023

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:40 AM

HOW AI WILL CHANGE MEDICINE

The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.

 

Adrian Aoun, CEO and Founder, Forward

Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health

Julie Sweet, Chief Executive Officer, North America, Accenture

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

018

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

7:45 AM

CONCURRENT BREAKFAST SOLUTION SESSIONS

WEAPONIZING YOUR OWN BODY

The newest tool in the medical arsenal is also the oldest: the human body itself. From patient blood cells modified to become cancer killers to molecules that release the reins on our internal Green Berets, the immune system may be modern medicine’s most effective commando force. But weaponizing the body doesn’t come cheap—with new drugs now listing in the high six figures and development costs running many times that amount. From CAR-Ts to souped-up stem cells to anticancer viruses, here’s what’s driving the wildest discovery engine in science—and what still stands in our way.

Dr. Anna Barker, Co-Director, Complex Adaptive Systems, Professor, School of Life Sciences, Arizona State University

 

Dr. Laurie Glimcher, President and CEO, Dana-Farber Cancer Institute

Dr. Thomas Lynch, Jr., Vice President, Chief Scientific Officer, Research and Development, Bristol-Myers Squibb

Dr. Jill O’Donnell-Tormey, Chief Executive Officer and Director of Scientific Affairs, Cancer Research Institute

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

092023

Andi Lanuza

 

Brainstormer 4 - Vengeance for a Crime, Naval, Baker

 

Given three random words, we were tasked to come up with a piece that would contain these words. This is what I came up with.

 

So Bill, the baker, sends muffins to his former friend and his enemy now, Joe, who works at the navy. He poisons the muffins he sent him as revenge for the times Joe has stolen his muffins from his bakery a couple of years back.

029

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

12:00 PM

THE SMARTPHONE-ACID DOPAMINE-DRIVEN FEEDBACK LOOPS

Why you’re an addict and you don’t even know it: A 21st century dilemma.

 

Tristan Harris, Co-founder, Time Well Spent

 

Photograph by Stuart Isett/Fortune

038

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

2:55 PM

FOLLOW THE GAZE: WHAT WEBCAM EYE-TRACKING CAN TEACH US

Our eyes and the way we look at our screens have the potential to unlock crucial data that can transform the way we are treated. A demonstration of one of the most eye-opening new diagnostic technologies coming down the pike.

 

Dr. Alexandra Papoutsaki, Assistant Professor in Computer Science, Pomona College

 

Photograph by Stuart Isett/Fortune

021

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:30 AM

THE POWER OF BEDSIDE DATA

A technology that monitors a person’s respiratory rate, heart rate and movement may not seem, at first, like much of an innovation—but consider that EarlySense does this by way of a sensor slipped under your mattress. That allows staff at anywhere from hospitals to nursing homes keep an electronic eye on non-critical patients’ vital signs—in a way that doesn’t have to be invasive. Princess and the Pea: Meet the digital age.

 

Dr. Karissa Price-Rico, COO, EarlySense Ltd.

  

Photograph by Stuart Isett/Fortune

023

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:40 AM

HOW AI WILL CHANGE MEDICINE

The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.

 

Adrian Aoun, CEO and Founder, Forward

Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health

Julie Sweet, Chief Executive Officer, North America, Accenture

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

004

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:45 PM

MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM

Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.

 

Deborah DiSanzo, General Manager, IBM Watson Health

Amy Powell, President, Paramount Television and Digital Entertainment

Bernard J. Tyson, Chairman and CEO, Kaiser Permanente

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm Tech 2019

MONDAY, JULY 15, 2019

Aspen, CO

 

7:00AM – 9:30AM

MAROON BELLS BIKE RIDE

Annual 25-mile bike ride up Castle Creek Valley to Maroon Lake, with views of Maroon Bells, and then downhill back to the St. Regis Aspen

 

Photograph by Fortune Magazine

Creative thinking and brainstorming day

Uploaded with the Flock Browser

026

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

11:10 AM

A MOTHER FIGHTS BACK: USING BIG DATA AND GENOMICS TO SILENCE HER SON’S KILLER

Theresa Beech’s 13-year-old son Daniel died nearly two years ago from osteosarcoma. Daniel’s killer: a pediatric bone cancer whose treatment—and survival rates—haven’t changed in 30 years. But the time for change is now. Driven by the hope that she can spare other families this same pain and loss, Theresa — a space engineer by day — has collected the genetic codes from more than 100 young patients whose parents donated the data. What she has discovered offers hope for progress at last. The unbelievable story of one woman’s race to cure a terrible cancer.

 

Theresa Beech, President, Because of Daniel

 

Photograph by Stuart Isett/Fortune

001

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

11:30 AM–1:00 PM

OPENING LUNCH: THE MOMENT OF TRUTH FOR DRUG DEVELOPMENT

Hosted by PAREXEL

 

The rising cost of failure. Lack of productivity gains. Intense pressure on prices and escalating demands to demonstrate value. All these factors are threatening the sustainability of pharmaceutical development, at a time when advances in medical science should be translating into significant gains for the industry and society. But a new class of technologies and patient-centric approaches may soon alter the playing field in a big way, allowing drug developers to leverage everything from real world data, to the use of precision medicine and cross-silo collaboration—driving up success rates and the value proposition for new medicines. We dig into the latest marvels in pharmaceutical development, discuss new research findings and probe how the transformative role of data might prove decisive for the future of the industry.

 

Dr. Udit Batra, CEO, MilliporeSigma

David Humphreys, Head of Healthcare U.S., Economist Intelligence Unit

Bernard Munos, Senior Fellow, FasterCures, a center of the Milken Institute

Paul Rejto, Executive Director and Head of Oncology Translational Research, Pfizer

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Editor-in-Chief, Fortune and Co-chair, Brainstorm Health

Introduction by: Dr. Alberto Grignolo, Corporate Vice President, Global Strategy, PAREXEL Consulting

  

Photograph by Stuart Isett/Fortune

006

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

3:35 PM

IN DEFENSE OF SCIENCE

We live in a time of mind-boggling change and technological advance. Cars drive themselves. Robots perform surgery. Phones can probe the connections of the universe. And humans edit the molecular instructions that shape their very humanity. Yet even as we hurtle through this futuristic present, swept up in discovery and innovation, a surprisingly powerful force is pushing back from the horizon: the fear of science. That force has rallied to challenge the foundation of science itself, undermining scientific research—and, yes, public health and safety. Now, more than ever, the field requires investment and talent, both of which are imperiled. How can we most effectively respond to this assault? What can be done to restore trust in science and fact? And how can we promote investment in science, and draw a new generation of enterprising thinkers to the field?

Dr. Susan Desmond-Hellmann, Chief Executive Officer, Bill & Melinda Gates Foundation

Dr. Margaret Hamburg, President, American Association for the Advancement of Science

Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

Degree show piece 2 -

BA (Hons) Textile Art Winchester School of Art, 2005.

004

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:45 PM

MENTAL HEALTH: THE MISSING LINK ON THE HEALTH CARE CONTINUUM

Mental health disorders are the leading cause of disability worldwide, and yet too often, we treat them as a separate domain from human health: We cut off the head from the body, as Kaiser Permanente CEO Bernard J. Tyson puts it. This separation isn’t just wrongheaded, say public health experts, it’s dangerous. An extraordinary conversation about changing that paradigm—from clinic to culture. How insights into depression, anxiety, and addiction can offer surprising clues to where the body breaks down, how to fix it….and, yes, how to talk about it.

 

Deborah DiSanzo, General Manager, IBM Watson Health

Amy Powell, President, Paramount Television and Digital Entertainment

Bernard J. Tyson, Chairman and CEO, Kaiser Permanente

Moderator: Arianna Huffington, Thrive Global

 

Photograph by Stuart Isett/Fortune

001A

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

  

1:00-1:45 PM

SPEAKER RECEPTION

 

Photograph by Stuart Isett/Fortune

Creative thinking and brainstorming day

Uploaded with the Flock Browser

022

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:35 AM

CAN A MACHINE STAFF YOUR HOSPITAL?

It has been called the great mismatch: legions of applicants for today’s 21st-century jobs aren’t prepared for the many positions available; meanwhile tens of thousands of talented people aren’t getting to put their skills to use—and the challenge is particularly acute in the health care economy. Meet the founder of one startup who believes she has the solution: using machine learning to find people with the traits most likely to make them great performers.

 

Kristen Hamilton, CEO and Co-founder, Koru

 

Photograph by Stuart Isett/Fortune

093909

Mina Velando

 

benefaction

underwater

thief

002

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:05 PM

SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT

The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.

 

The Fortune Brainstorm Health Co-Chairs:

Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health

Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health

Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

092032

Jenny Lapus

 

Brainstormer 5 - Conviction, Klondike, Clock

This is an advertisement for the Flava Flav Klondike Collection. There is a testimonial from a man named Henry who has a strong conviction that this deck of cards is "WONDERFULL!!!!!!1111"

(I chose to feature Flava Flav on the cards because he is a celebrity famous for his huge clock necklaces)

023

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

9:40 AM

HOW AI WILL CHANGE MEDICINE

The Age of AI is now in its infancy. But even at this early stage, many in the field are convinced it will transform virtually every facet of the health care industry, from individual risk assessment to drug development to precision diagnostics to therapeutic design. A (sober) conversation on how machine-driven insights will help us decipher biology’s endless complexity—and where the big payoffs will come.

 

Adrian Aoun, CEO and Founder, Forward

Dr. Suchi Saria, Director, Machine Learning and Healthcare Lab, Johns Hopkins University; Founder and CEO, Bayesian Health

Julie Sweet, Chief Executive Officer, North America, Accenture

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

014

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

7:00 PM–9:00 PM

DINNER AND FEATURED INTERVIEW

Hosted by IBM Watson Health

 

WELCOME

Deborah DiSanzo, General Manager, IBM Watson Health

 

THE SECRET TO TONY ROBBINS’ SUCCESS

He’s the go-to life and business strategist for high-octane CEOs, athletes, celebrities, and politicians. And, his empire of seminars, books, audio, video, and life training programs has empowered more than 50 million people from 100 countries who may not be lucky enough to have him on speed dial. Tony Robbins insists he can teach anyone to be confident, but where did the CEO Whisperer’s own strength come from? Fresh from another wildly popular “Unleash the Power Within” event, here’s Robbins as you’ve never seen him before. Joining us for an intimate interview in which he shares his own difficult personal upbringing, Robbins reveals how he went from homeless to household name—and how he can teach anyone else to believe in themselves.

 

Tony Robbins, Life and Business Strategist; Author, Unshakeable, Money: Master the Game

Interviewer: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

012

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:35 PM

THE NEXT BIG THING

When it comes to improving our health care systems through technology, the good ideas seem to be never-ending. Digital invention is plentiful; funding is rich. But so far, we’ve yet to see anything that moves the needle more than a little bit. Which brings us to a tough question: Is there a next big thing in healthtech—something that’s going to change human health or care the minute it comes into existence? And if so, where will it come from? Our conversation with two visionaries in the field.

 

Dr. Jessica Mega, Chief Medical Officer, Verily

Dr. Bryan Roberts, Partner, Venrock

Moderator: Michal Lev-Ram, Senior Writer and Co-chair, Most Powerful Women Summit, MPW Next Gen, and Brainstorm TECH, Fortune

 

Photograph by Stuart Isett/Fortune

026

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

11:10 AM

A MOTHER FIGHTS BACK: USING BIG DATA AND GENOMICS TO SILENCE HER SON’S KILLER

Theresa Beech’s 13-year-old son Daniel died nearly two years ago from osteosarcoma. Daniel’s killer: a pediatric bone cancer whose treatment—and survival rates—haven’t changed in 30 years. But the time for change is now. Driven by the hope that she can spare other families this same pain and loss, Theresa — a space engineer by day — has collected the genetic codes from more than 100 young patients whose parents donated the data. What she has discovered offers hope for progress at last. The unbelievable story of one woman’s race to cure a terrible cancer.

 

Theresa Beech, President, Because of Daniel

 

Photograph by Stuart Isett/Fortune

009

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

4:40 PM

THE MOTHER OF INVENTION

Necessity isn’t the mother of invention, creativity is. But where do you find the special spark that can help transform a product from merely a “cool” piece of tech to a must-have that can change lives for the better? And, in an age when billions of dollars are being pumped into digital health and medical technology ventures, how can stakeholders identify the most promising innovations? A conversation with some of the most creative minds in the health space.

 

James Park, Co-founder and CEO, Fitbit

Dr. Martine Rothblatt, Chairman and Chief Executive Officer, United Therapeutics Corp.

Moderator: Sue Siegel, Chief Innovation Officer, GE; Chief Executive Officer, GE Ventures

 

Photograph by Stuart Isett/Fortune

011

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

5:10 PM

PRECISION MEDICINE: WHERE IT’S WORKING AND WHY

The tools of molecular medicine, today, are homing in on human disease with a precision that could only be imagined a decade ago. New advances in big data, genomic medicine, and supercomputing are paving the way for targeted, personalized treatment. What has been the clinical impact so far—and what can we really expect in the five years to come? A deep dive with three individuals who are putting these tools into practice.

 

Kathy Giusti, Founder, Multiple Myeloma Research Foundation (MMRF); Faculty Co-chair, Kraft Precision Medicine Accelerator, Harvard Business School

Othman Laraki, Co-Founder and CEO, Color

Dr. Vijay Pande, General Partner, Andreessen Horowitz

Moderator: Dr. David B. Agus, University of Southern California

 

Photograph by Stuart Isett/Fortune

002

Fortune Brainstorm HEALTH 2018

Monday, March 19th, 2018

Laguna Niguel, CA

 

2:05 PM

SETTING THE AGENDA: A BRAINSTORM HEALTH 3.0 REBOOT

The health ecosystem is evolving faster than ever before, as everything—from machine learning to biotracking to gene editing—advances with breakneck speed. But whether these innovations will transform global health for the better depends on something else: leadership. Today, those who run and shape every enterprise need to be health care leaders too. So we’ve framed our third annual gathering not just as an incubator of ideas, but also as a leadership summit. Our goals? To help you harness the power of innovation for your company and community—and to share smart solutions that can make all of us thrive a little bit more.

 

The Fortune Brainstorm Health Co-Chairs:

Dr. David B. Agus, Professor of Medicine and Engineering; Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine, University of Southern California; Co-chair, Fortune Brainstorm Health

Arianna Huffington, Founder and CEO, Thrive Global; Co-chair, Fortune Brainstorm Health

Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

035

Fortune Brainstorm HEALTH 2018

Tuesday, March 20th, 2018

Laguna Niguel, CA

 

1:00 PM

CONCURRENT LUNCH SOLUTION SESSIONS

PATIENT TRIALS WE CAN ACTUALLY LEARN FROM

Hosted by City of Hope

The cost to develop and gain FDA approval for a new drug today is more than $2.5 billion, according to the Tufts Center for the Study of Drug Development. Driving much of that cost are human clinical trials—a process that has long been the intellectual and regulatory scaffold supporting the drug development enterprise, and one that has barely changed over the past seven decades. Despite all that expenditure—which ultimately helps push up the price of medicines—we still often know little about whether even approved drugs will work in any one individual and why. Luckily, there are a number of innovative ideas for evaluating the safety and efficacy of new medicines that may give us more information, more quickly—and maybe even more cheaply too. A no-holds-barred roundtable.

Dr. Amy Abernethy, Chief Medical Officer, Chief Scientific Officer, and Senior Vice President, Oncology, Flatiron Health

 

Matt de Silva, Co-Founder, CEO and Director, Notable Labs

Kathy Giusti, Founder, Multiple Myeloma Research Foundation; Co-Chair, HBS Kraft Precision Medicine Accelerator

Dr. Linda Malkas, Professor and Associate Chair, Department of Molecular and Cellular Biology, City of Hope

Dr. Lesley Stolz, Head, JLABS Bay Area, Johnson & Johnson Innovation

Moderator: Clifton Leaf, Fortune

 

Photograph by Stuart Isett/Fortune

Brainstorming with an IT team at UVa on how their current process works.

Brainstorm @ Metalcamp 2008

1 2 ••• 75 77 78 79 80